SCHEMBL6316974

SCHEMBL6316974

O=C(OCc1ccccc1)N1CC2CN(Cc3ccccc3)CC2C1c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.47
S1PR5 Q9H228 2/20 0.44
TMEM97 Q5BJF2 2/20 0.43
SIGMAR1 Q99720 2/20 0.43
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
CCR5 P51681 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
S1PR1 P21453 1/20 0.41
CACNA1G O43497 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6319234 0.86 GRIN2B (0.49) GRIN2BS1PR5S1PR1
SCHEMBL6310196 0.85 CACNA1G (0.44) GRIN2BS1PR5TMEM97SIGMAR1PSEN1
SCHEMBL6317296 0.81 DRD2 (0.41) GRIN2BS1PR5TMEM97SIGMAR1CACNA1G
SCHEMBL6311540 0.80 CCR5 (0.46) S1PR5PSEN1PSEN2APH1BNCSTN
SCHEMBL6486032 0.74 GRIN2B (0.49) GRIN2BS1PR5S1PR1
SCHEMBL20587395 0.72 AGTR2 (0.48) S1PR5TMEM97SIGMAR1PSEN1PSEN2
SCHEMBL6319094 0.72 ALDH1A1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL25390328 0.72 GRIN2B (0.47) GRIN2BS1PR5SIGMAR1S1PR1
SCHEMBL25388147 0.72 GRIN2B (0.47) GRIN2BS1PR5SIGMAR1S1PR1
SCHEMBL14646619 0.72 PDK1 (0.59) TMEM97SIGMAR1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043354-A1 NK1 antagonist PFIZER INC 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043354-A1 NK1 antagonist TACR2, TACR1, TAC3 GRIN2B 296/4885S1PR5 184/4885TMEM97 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.